Black Diamond Therapeutics and Ideaya Biosciences are mulling over registrational trials for their lead assets after ...

Discover the ultimate test of skill with our roundup of the 10 most challenging downhill mountain bike trails.

A team of 14 professionals has launched Matauro, which will use Fidelity for custody and Purshe Kaplan Sterling Investments ...

The 555.55 carat black diamond has belonged to its current owner for two decades but little is known about its history before that. A billion-year-old black diamond, believed to be the largest cut ...

The Dow Jones closed lower by around 250 points on Thursday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders ...

Black Diamond Therapeutics, Inc. (BDTX) announced positive initial Phase 2 results for BDTX-1535 in patients with relapsed or ...

“Patients often become resistant to osimertinib with the emergence of on-target resistance EGFR mutations,” said Sergey Yurasov, Chief Medical Officer of Black Diamond Therapeutics.

Shares in Black Diamond Therapeutics rose after the company outlined positive initial data from Phase 2 trials of BDTX-1535, an oral cancer treatment. Shares were up 46% in premarket trading at $6.94.

Our favorite option is from Orzly. It’s designed specifically for the Portal, offering a matching black and white colorway. A few other colors are even available for a flashier look. The Orzly ...

Heaven's Door, Kishibe Rohan's Stand, can turn people into books, making it one of the most overpowered Stands. JoJo's ...

Robert Burns, an analyst from H.C. Wainwright, reiterated the Buy rating on Black Diamond Therapeutics (BDTX – Research Report). The ...